These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3055567)

  • 21. Malaria vaccine.
    Khurana SK; Talib VH
    Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of protective immunity to malaria.
    Anders RF; Brown GV; Coppel RL; Kemp DJ
    Lepr Rev; 1986 Dec; 57 Suppl 2():245-53. PubMed ID: 3553798
    [No Abstract]   [Full Text] [Related]  

  • 23. Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3.
    Daubersies P; Thomas AW; Millet P; Brahimi K; Langermans JA; Ollomo B; BenMohamed L; Slierendregt B; Eling W; Van Belkum A; Dubreuil G; Meis JF; Guérin-Marchand C; Cayphas S; Cohen J; Gras-Masse H; Druilhe P
    Nat Med; 2000 Nov; 6(11):1258-63. PubMed ID: 11062538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence polymorphisms in the receptor-binding domain of Plasmodium falciparum EBA-175: implications for malaria vaccine development.
    Mamillapalli A; Pattnaik P; Sharma M; Sharma SK; Tyagi PK; Joshi H; Chitnis CE
    Mol Biochem Parasitol; 2006 Mar; 146(1):120-3. PubMed ID: 16359738
    [No Abstract]   [Full Text] [Related]  

  • 25. Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines.
    Miao J; Li X; Liu Z; Xue C; Bujard H; Cui L
    Vaccine; 2006 Sep; 24(37-39):6187-98. PubMed ID: 16806600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant activity of polymer microparticles and Montanide ISA 720 on immune responses to Plasmodium falciparum MSP2 long synthetic peptides in mice.
    Mata E; Carcaboso AM; Hernández RM; Igartua M; Corradin G; Pedraz JL
    Vaccine; 2007 Jan; 25(5):877-85. PubMed ID: 17070628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasmodium falciparum CS C-terminal fragment: preclinical evaluation and phase I clinical studies.
    Roggero MA; Weilenmann C; Bonelo A; Audran R; Renggli J; Spertini F; Corradin G; López JA
    Parassitologia; 1999 Sep; 41(1-3):421-4. PubMed ID: 10697896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parasitology. Malaria--from infants to genomics to vaccines.
    Long CA; Hoffman SL
    Science; 2002 Jul; 297(5580):345-7. PubMed ID: 12130768
    [No Abstract]   [Full Text] [Related]  

  • 29. Malaria. Effective vaccine for humans?
    Miller LH
    Nature; 1988 Mar; 332(6160):109-10. PubMed ID: 3279317
    [No Abstract]   [Full Text] [Related]  

  • 30. Detection of antibodies to Plasmodium falciparum sporozoites by employing synthetic peptides.
    Del Giudice G; Biro S; Degrémont AA; Engers HD; Lambert PH; Pessi A; Tougne C; Verdini AS; Weiss N; Tanner M
    Parassitologia; 1986; 28(2-3):107-11. PubMed ID: 3332303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baculovirus-expressed constructs induce immunoglobulin G that recognizes VAR2CSA on Plasmodium falciparum-infected erythrocytes.
    Barfod L; Nielsen MA; Turner L; Dahlbäck M; Jensen AT; Hviid L; Theander TG; Salanti A
    Infect Immun; 2006 Jul; 74(7):4357-60. PubMed ID: 16790811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conserved polypeptides of Plasmodium falciparum as malaria vaccine candidates?
    Herrera S; Herrera MA; Clavijo C; Corredor A; Certa U
    Acta Leiden; 1991; 60(1):107-10. PubMed ID: 1820697
    [No Abstract]   [Full Text] [Related]  

  • 33. [Can malaria be eradicated by vaccination?].
    Stürchler D
    Schweiz Rundsch Med Prax; 1987 Sep; 76(36):975-80. PubMed ID: 3310179
    [No Abstract]   [Full Text] [Related]  

  • 34. Evidence for a 6.5-day minimum exoerythrocytic cycle for Plasmodium falciparum in humans and confirmation that immunization with a synthetic peptide representative of a region of the circumsporozoite protein retards infection.
    Murphy JR; Baqar S; Davis JR; Herrington DA; Clyde DF
    J Clin Microbiol; 1989 Jul; 27(7):1434-7. PubMed ID: 2671011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malaria--any hopes?
    Joshi VR; Sainani GS
    J Assoc Physicians India; 1987 Mar; 35(3):181-2. PubMed ID: 3301794
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospects and problems for malaria vaccination: an African perspective.
    Mulla AF
    East Afr Med J; 1988 Apr; 65(4):219-23. PubMed ID: 3049043
    [No Abstract]   [Full Text] [Related]  

  • 38. Peptides inducing short-lived antibody responses against Plasmodium falciparum malaria have shorter structures and are read in a different MHC II functional register.
    Patarroyo ME; Alba MP; Vargas LE; Silva Y; Rosas J; Rodríguez R
    Biochemistry; 2005 May; 44(18):6745-54. PubMed ID: 15865420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sporozoite and liver stage antigen Plasmodium falciparum peptides bind specifically to human hepatocytes.
    Puentes A; García J; Vera R; López R; Suarez J; Rodríguez L; Curtidor H; Ocampo M; Tovar D; Forero M; Bermudez A; Cortes J; Urquiza M; Patarroyo ME
    Vaccine; 2004 Mar; 22(9-10):1150-6. PubMed ID: 15003642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malaria. Getting into the liver.
    Cox FE
    Nature; 1992 Oct; 359(6394):361-2. PubMed ID: 1406943
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.